Abivax (AAVXF) Goodwill (2022 - 2025)

Abivax has reported Goodwill over the past 4 years, most recently at $21.4 million for Q4 2025.

  • Quarterly results put Goodwill at $21.4 million for Q4 2025, up 8.93% from a year ago — trailing twelve months through Dec 2025 was $21.4 million (up 8.93% YoY), and the annual figure for FY2025 was $20.8 million, up 4.39%.
  • Goodwill for Q4 2025 was $21.4 million at Abivax, up from $19.7 million in the prior quarter.
  • Over the last five years, Goodwill for AAVXF hit a ceiling of $21.4 million in Q4 2025 and a floor of $18.8 million in Q4 2022.
  • Median Goodwill over the past 4 years was $19.8 million (2023), compared with a mean of $19.9 million.
  • Biggest five-year swings in Goodwill: decreased 0.68% in 2024 and later rose 8.93% in 2025.
  • Abivax's Goodwill stood at $18.8 million in 2022, then grew by 5.46% to $19.8 million in 2023, then fell by 0.68% to $19.7 million in 2024, then increased by 8.93% to $21.4 million in 2025.
  • The last three reported values for Goodwill were $21.4 million (Q4 2025), $19.7 million (Q4 2024), and $19.8 million (Q4 2023) per Business Quant data.